These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36979894)

  • 1. Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments.
    Kishino Y; Fukuda K
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.
    Yoshida A; Sekine W; Homma J; Sekine H; Itoyama YY; Sasaki D; Matsuura K; Kobayashi E; Shimizu T
    Regen Ther; 2022 Dec; 21():413-423. PubMed ID: 36248630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
    Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
    Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial.
    Zhang H; Xue Y; Pan T; Zhu X; Chong H; Xu C; Fan F; Cao H; Zhang B; Pan J; Zhou Q; Yang G; Wang J; Wang DJ
    BMJ Open; 2022 May; 12(5):e056264. PubMed ID: 35523485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 11. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Cardiac Regenerative Medicine Using Human iPS Cell-derived Cardiomyocytes.
    Fujita J
    Keio J Med; 2021 Sep; 70(3):53-59. PubMed ID: 32830153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-Edited Human-Induced Pluripotent Stem Cell Lines to Elucidate
    Inácio JM; Nunes MM; Almeida M; Cristo F; Anjos R; Belo JA
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, in Contrast to Adipose Tissue-Derived Stromal Cells, Efficiently Improve Heart Function in Murine Model of Myocardial Infarction.
    Stępniewski J; Tomczyk M; Andrysiak K; Kraszewska I; Martyniak A; Langrzyk A; Kulik K; Wiśniewska E; Jeż M; Florczyk-Soluch U; Polak K; Podkalicka P; Kachamakova-Trojanowska N; Józkowicz A; Jaźwa-Kusior A; Dulak J
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33297443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.
    Yamoah MA; Moshref M; Sharma J; Chen WC; Ledford HA; Lee JH; Chavez KS; Wang W; López JE; Lieu DK; Sirish P; Zhang XD
    Int J Nanomedicine; 2018; 13():6073-6078. PubMed ID: 30323594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells.
    Soma Y; Morita Y; Kishino Y; Kanazawa H; Fukuda K; Tohyama S
    Front Cardiovasc Med; 2021; 8():774389. PubMed ID: 34957258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids.
    Tan Y; Richards D; Coyle RC; Yao J; Xu R; Gou W; Wang H; Menick DR; Tian B; Mei Y
    Acta Biomater; 2017 Mar; 51():495-504. PubMed ID: 28087483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the cardiomyocyte differentiation potential of induced pluripotent stem cells reprogrammed from human atrial or ventricular fibroblasts.
    Wang L; Nguyen T; Rosa-Garrido M; Zhou Y; Cleveland DC; Zhang J
    Front Bioeng Biotechnol; 2023; 11():1108340. PubMed ID: 36845191
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair.
    He X; Liang J; Paul C; Huang W; Dutta S; Wang Y
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.